Prostate News and Research

RSS

Routine referral of prostate cancer patients to a cardiovascular specialist fails to cut cardiac events

Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy.

31 Aug 2026

Study identifies KRAS G12C as a precision-medicine target in genitourinary cancers

A new research paper was published in Volume 17 of Oncotarget on August 19, 2026, titled "Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine."

28 Aug 2026

Study shows how cancer can act as a systemic disease

In their quest to understand how cancers take root, grow and spread, scientists have for the past half-century explored the genetic aberrations and microenvironmental peculiarities of tumors and their constituent cells.

28 Aug 2026

Study links finasteride to fewer complications after heart attack in men

Patients treated with medication for benign prostatic hyperplasia at the time of a severe acute heart attack experienced fewer serious complications from the attack, according to a study from the University of Gothenburg.

26 Aug 2026

SBRT improves bowel health related quality-of-life in patients with localized intermediate-risk prostate cancer

Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) to moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate risk prostate cancer indicate that the use of SBRT improved bowel health related quality of life (HRQOL) in this patient population.

25 Aug 2026

Targeting cyclin-dependent kinases offers new pathways for cancer therapy

Cancer is the second leading cause of death in Germany. In the search for new therapeutic approaches that target the uncontrolled growth of tumor cells, a class of enzymes known as cyclin-dependent kinases (CDKs) has come into focus.

24 Aug 2026

Study shows how prostate tumors rewire metabolism to resist therapy

Prostate tumors can rewire amino acid metabolism to override the normal brakes on cholesterol production, a process that may fuel hormone therapy resistance, according to a study by Weill Cornell Medicine investigators.

20 Aug 2026

New study links chronic stress to immunotherapy resistance in tumors

Immunotherapy has transformed cancer treatment, yet many tumors remain stubbornly resistant to its effects.

18 Aug 2026

Deep-learning tissue clocks reveal how organs age and leave disease-linked signals in blood

Deep learning applied to more than 25,000 histopathology slides revealed tissue-specific structural signatures of biological aging that tracked telomere attrition, pathology, comorbidity, and molecular changes more closely than chronological age alone.

18 Aug 2026

Aircrews face highest risk of radiation-related cancer deaths

Of more than 500 occupations in the United States, flight attendants and pilots have the highest and second-highest proportion of radiation-related cancer deaths, a new study has found.

17 Aug 2026

New method enables more precise labeling of protein-protein interactions in cancer-specific cells

Using a photochemically driven labeling technique, a Cornell University-led research group has devised a strategy for capturing cancer-specific protein-to-protein interactions, which could one day spawn targeted therapies for prostate, small-cell lung, pancreatic and other deadly forms of the disease.

14 Aug 2026

Most veterans with low-risk prostate cancer choose active surveillance

Three decades after UC San Francisco pioneered "active surveillance" for patients with low-risk prostate cancer, a new study has found that the vast majority of veterans with the diagnosis pursued this option instead of treatment.

13 Aug 2026

AI model predicts cancer subtype, genetic mutations, and survival outcomes across 32 solid tumors

Researchers have developed a novel AI model that can analyze a routine whole histopathology image and simultaneously predict cancer subtype, specific genetic mutations, and survival outcomes across 32 different solid cancers rather than focusing on a single cancer type.

13 Aug 2026

What is the optimal prostate-specific antigen cutoff to determine the success of prostate cancer treatment?

After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that the treatment is working.

13 Aug 2026

Ultra-processed foods linked to higher prostate cancer risk in men

Ultra-processed foods (UPFs) account for nearly 60% of adults' and 70% of children's energy intake in the United States.

12 Aug 2026

Genetic tool turns soft cancer cells into immune targets

Researchers at the USC Viterbi School of Engineering and Keck School of Medicine of USC have engineered a remarkable genetic tool that addresses one of the most persistent obstacles in cancer immunotherapy: the physical softness of tumors.

11 Aug 2026

Traditional prostate cancer features fail to predict hormone therapy benefit

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while traditional pathological features used to classify aggressive prostate cancer -such as high-grade disease, cancer extending outside the prostate and cancer involving the seminal vesicles- after surgery can help identify patients who are more likely to have worse outcomes, they do not predict who will benefit more from adding hormone therapy to postoperative radiation.

10 Aug 2026

Optimal prostate-specific antigen cutoff linked to improved prostate cancer survival

After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that the treatment is working.

10 Aug 2026

Early radionuclide therapy delays progression in metastatic prostate cancer

Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and investigators at several other institutions worldwide.

6 Aug 2026

Tuft cell-like cancers exhibit unique biological characteristics across multiple organs

A growing body of evidence suggests that a rare epithelial cell type known as the tuft cell may play a far more significant role in cancer than previously recognized.

6 Aug 2026

Prostate News and Research

Routine referral of prostate cancer patients to a cardiovascular specialist fails to cut cardiac events

Study identifies KRAS G12C as a precision-medicine target in genitourinary cancers

Study shows how cancer can act as a systemic disease

Study links finasteride to fewer complications after heart attack in men

SBRT improves bowel health related quality-of-life in patients with localized intermediate-risk prostate cancer

Targeting cyclin-dependent kinases offers new pathways for cancer therapy

Study shows how prostate tumors rewire metabolism to resist therapy

New study links chronic stress to immunotherapy resistance in tumors

Deep-learning tissue clocks reveal how organs age and leave disease-linked signals in blood

Aircrews face highest risk of radiation-related cancer deaths

New method enables more precise labeling of protein-protein interactions in cancer-specific cells

Most veterans with low-risk prostate cancer choose active surveillance

AI model predicts cancer subtype, genetic mutations, and survival outcomes across 32 solid tumors

What is the optimal prostate-specific antigen cutoff to determine the success of prostate cancer treatment?

Ultra-processed foods linked to higher prostate cancer risk in men

Genetic tool turns soft cancer cells into immune targets

Traditional prostate cancer features fail to predict hormone therapy benefit

Optimal prostate-specific antigen cutoff linked to improved prostate cancer survival

Early radionuclide therapy delays progression in metastatic prostate cancer

Tuft cell-like cancers exhibit unique biological characteristics across multiple organs

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News